Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis-Reference-Cited by-同舟云学术

Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis

Published:2021-04 Issue:8 Volume:184 Page:2033-2052.e21
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Kaczanowska Sabina^ORCID,Beury Daniel W.,Gopalan Vishaka,Tycko Arielle K.,Qin Haiying^ORCID,Clements Miranda E.,Drake Justin^ORCID,Nwanze Chiadika^ORCID,Murgai Meera,Rae Zachary,Ju Wei,Alexander Katherine A.,Kline Jessica^ORCID,Contreras Cristina F.^ORCID,Wessel Kristin M.,Patel Shil^ORCID,Hannenhalli Sridhar,Kelly Michael C.,Kaplan Rosandra N.

Funder

NCI

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference112 articles.

1. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice;Albrengues;Science,2018

2. Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression;Awad;Front. Immunol.,2018

3. Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2;Beury;J. Immunol.,2016

4. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis;Bonapace;Nature,2014

5. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration;Bracci;Clin Cancer Res,2007

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GBM immunotherapy: Exploring molecular and clinical frontiers;Life Sciences;2024-11

2. NAC1 promotes stemness and regulates myeloid-derived cell status in triple-negative breast cancer;Molecular Cancer;2024-09-06

3. Characterizing the role of exosomal miRNAs in metastasis;2024-08-21

4. Intratumoral Delivery of Genetically Engineered Anti-IL-6 Trans-signaling Therapeutics;Molecular Biotechnology;2024-07-09

5. Intraperitoneal activation of myeloid cells clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer;2024-06-29